These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16353448)

  • 1. Acute allergic reaction upon first exposure to gadolinium-DTPA: a case report.
    Rahman SL; Harbinson MT; Mohiaddin R; Pennell DJ
    J Cardiovasc Magn Reson; 2005; 7(5):849-51. PubMed ID: 16353448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates.
    Li A; Wong CS; Wong MK; Lee CM; Au Yeung MC
    Br J Radiol; 2006 May; 79(941):368-71. PubMed ID: 16632615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of magnetic resonance imaging contrast agents.
    Shellock FG; Kanal E
    J Magn Reson Imaging; 1999 Sep; 10(3):477-84. PubMed ID: 10508312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What are the remaining indications for gadolinium contrast in CT].
    Clément O
    J Radiol; 2009 Mar; 90(3 Pt 1):261. PubMed ID: 19421108
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute pancreatitis induced by magnetic-resonance-imaging contrast agent.
    Terzi C; Sökmen S
    Lancet; 1999 Nov; 354(9192):1789-90. PubMed ID: 10577645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of gadobenate dimeglumine in a patient with reported allergy to gadoterate meglumine.
    Moulin C; Said BB; Berard F
    AJR Am J Roentgenol; 2011 Dec; 197(6):W1163. PubMed ID: 22109336
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe adverse reactions with contrast agents for magnetic resonance: clinical experience in 30,000 MR examinations.
    De Ridder F; De Maeseneer M; Stadnik T; Luypaert R; Osteaux M
    JBR-BTR; 2001 Aug; 84(4):150-2. PubMed ID: 11688727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium and kidney disease: are your patients at risk?
    Hollister D
    Nephrol Nurs J; 2008; 35(2):196-7. PubMed ID: 18472687
    [No Abstract]   [Full Text] [Related]  

  • 10. Anaphylaxis to gadolinium radiocontrast: a case report and review of the literature.
    Shepherd M; Lata S; Mani S; Fiorillo A; Kumar P
    J La State Med Soc; 2009; 161(5):282-4. PubMed ID: 19927942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MR imaging diagnosis of myocardial infarction and an usefulness of Gd-DTPA].
    Watanabe S; Imazeki Y; Ishizuya Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):476-80. PubMed ID: 12436568
    [No Abstract]   [Full Text] [Related]  

  • 12. A word of caution on the use of high-dose MR contrast media in patients with renal failure.
    Geckeis K; Eggebrecht H; Quick HH; Barkhausen J; Kribben A; Erbel R
    J Endovasc Ther; 2005 Apr; 12(2):262. PubMed ID: 15823076
    [No Abstract]   [Full Text] [Related]  

  • 13. Morbidity of direct MR arthrography.
    Hall FM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1524. PubMed ID: 22109312
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatic chemoembolization in a patient allergic to iodinated contrast media: the use of Gd-DTPA].
    Balestreri L; Morassut S
    Radiol Med; 1999 Sep; 98(3):208-9. PubMed ID: 10575459
    [No Abstract]   [Full Text] [Related]  

  • 15. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
    Murphy KP; Szopinski KT; Cohan RH; Mermillod B; Ellis JH
    Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
    Nilsson S
    Acta Radiol Suppl; 1995; 397():1-44. PubMed ID: 7484207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohypocalcemia with MR imaging contrast agents: a cautionary tale.
    Choyke PL; Knopp MV
    Radiology; 2003 Jun; 227(3):627-8. PubMed ID: 12773668
    [No Abstract]   [Full Text] [Related]  

  • 18. An Acute Adverse Reaction with ST Elevation Induced by Magnetic Resonance Contrast Media: Kounis Syndrome.
    Tanaka H; Urushima M; Hirano S; Takenaga M
    Intern Med; 2019 Jan; 58(2):243-245. PubMed ID: 30146563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Grade Ⅲ Severe Hypersensitivity Caused by Gadopentatic Acid Injection: A Case Report.
    Chen Q; Qian Q
    J Emerg Nurs; 2023 Jul; 49(4):485-488. PubMed ID: 37002127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notes on "Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent".
    Runge VM
    AJR Am J Roentgenol; 2008 Jun; 190(6):1433-4. PubMed ID: 18492887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.